Completion Of Phase I Clinical Trial Of Sancuso(R) In Japanese Volunteers

Links shared publicly online about this topic.

1,632
total visits

Completion Of Phase I Clinical Trial Of Sancuso(R) In Japanese Volunteers

Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced the completion of a Phase I clinical trial for SP-01 (extended re

View full resource at medicalnewstoday.com

Tags: Pharma, Clinical Trial, Oncology

Most Recently Shared on November 2, 2009 at 3:37 pm By:

MNT Clinical Trials

Completion Of Phase I Clinical Trial Of Sancuso(R) In Japanese Volunteers: Solasia Pharma K.K., a developer of .. http://bit.ly/199s0L

3 years ago...

Retweet

Favorite

Solasia Pharma completes Phase I clinical trial for Sancuso extended release transdermal granisetron patch

news-medical.net — “Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the completion of a Phase I clinical trial for SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers.” View full resource at news-medical.net